Lipoprotein-associated and secreted phospholipases A₂ in cardiovascular disease: roles as biological effectors and biomarkers

Circulation. 2010 Nov 23;122(21):2183-200. doi: 10.1161/CIRCULATIONAHA.110.936393.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Atherosclerosis* / genetics
  • Atherosclerosis* / immunology
  • Atherosclerosis* / metabolism
  • Biomarkers / blood*
  • Group IV Phospholipases A2 / blood
  • Group IV Phospholipases A2 / genetics
  • Group IV Phospholipases A2 / metabolism
  • Group VI Phospholipases A2* / blood
  • Group VI Phospholipases A2* / genetics
  • Group VI Phospholipases A2* / metabolism
  • Humans
  • Inflammation / genetics
  • Inflammation / immunology
  • Inflammation / metabolism
  • Lipoproteins / blood*
  • Polymorphism, Genetic
  • Predictive Value of Tests
  • Prognosis

Substances

  • Biomarkers
  • Lipoproteins
  • Group IV Phospholipases A2
  • Group VI Phospholipases A2
  • PLA2G4A protein, human
  • PLA2G6 protein, human